Indacaterol Maleate/Glycopyrronium Bromide/Mometasone furoate
- Generic Name
- Indacaterol Maleate/Glycopyrronium Bromide/Mometasone furoate
A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.
Phase 3
Not yet recruiting
- Conditions
- Asthma
- Interventions
- Drug: Placebo to QVM149Drug: Run-In MedicationDrug: Rescue MedicationDevice: Concept 1 DeviceDevice: Girohaler
- First Posted Date
- 2023-03-20
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 304
- Registration Number
- NCT05776927
Anti-inflammatory Effects Glycopyrronium
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2023-01-12
- Lead Sponsor
- University Medical Center Groningen
- Target Recruit Count
- 28
- Registration Number
- NCT04259164
- Locations
- 🇳🇱
University Medical Center Groningen, Groningen, Netherlands
Investigating the Effects of QVM149 on MRI Ventilation Defects
- First Posted Date
- 2019-12-20
- Last Posted Date
- 2021-12-14
- Lead Sponsor
- Dr. Grace Parraga
- Registration Number
- NCT04206761
- Locations
- 🇨🇦
Robarts Research Insitute; The University of Western Ontario; London Health Sciences Centre, London, Ontario, Canada
Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + Tiotropium
Phase 3
Completed
- Conditions
- Asthma
- Interventions
- First Posted Date
- 2017-05-18
- Last Posted Date
- 2021-10-08
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 1426
- Registration Number
- NCT03158311
- Locations
- 🇻🇳
Novartis Investigative Site, Ho Chi Minh, Vietnam
A Long-term Safety Study of QVM149 in Japanese Patients With Asthma
- First Posted Date
- 2017-04-04
- Last Posted Date
- 2020-04-07
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 96
- Registration Number
- NCT03100825
- Locations
- 🇯🇵
Novartis Investigative Site, Toshima ku, Tokyo, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath